"Gelatin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A product formed from skin, white connective tissue, or bone COLLAGEN. It is used as a protein food adjuvant, plasma substitute, hemostatic, suspending agent in pharmaceutical preparations, and in the manufacturing of capsules and suppositories.
Descriptor ID |
D005780
|
MeSH Number(s) |
D12.776.860.476
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Gelatin".
Below are MeSH descriptors whose meaning is more specific than "Gelatin".
This graph shows the total number of publications written about "Gelatin" by people in this website by year, and whether "Gelatin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 0 | 1 | 1 |
1999 | 0 | 1 | 1 |
2004 | 0 | 1 | 1 |
2015 | 1 | 0 | 1 |
2021 | 0 | 1 | 1 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gelatin" by people in Profiles.
-
Development of a food grade sanitizer delivery system with chlorine loaded gelatin microgels for enhanced binding and inactivation of biofilms. Food Res Int. 2022 05; 155:111026.
-
Conductive and injectable hyaluronic acid/gelatin/gold nanorod hydrogels for enhanced surgical translation and bioprinting. J Biomed Mater Res A. 2022 02; 110(2):365-382.
-
Bead block embolization of a retinal arteriole. JAMA Ophthalmol. 2015 Feb; 133(2):156.
-
Paclitaxel gelatin nanoparticles for intravesical bladder cancer therapy. J Urol. 2011 Apr; 185(4):1478-83.
-
Formulation and evaluation of ciprofloxacin hydrochloride soluble ocular drug insert. Curr Eye Res. 2008 May; 33(5):469-75.
-
Formulating paclitaxel in nanoparticles alters its disposition. Pharm Res. 2005 Jun; 22(6):867-74.
-
Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy. Clin Cancer Res. 2004 Nov 15; 10(22):7677-84.
-
Ectopic production of MDA-7/IL-24 inhibits invasion and migration of human lung cancer cells. Mol Ther. 2004 Apr; 9(4):510-8.
-
Growth of human tumor cells in macroporous microcarriers results in p53-independent, decreased cisplatin sensitivity relative to monolayers. Mol Pharmacol. 1999 May; 55(5):938-47.
-
Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin. Biochem J. 1998 May 01; 331 ( Pt 3):965-72.